US 9181249
Substituted pyrido[3,4-b]pyrazines as GPR6 modulators
granted A61PA61P1/14A61P25/00
Quick answer
US patent 9181249 (Substituted pyrido[3,4-b]pyrazines as GPR6 modulators) held by Takeda Pharmaceutical Company Limited expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P1/14, A61P25/00, A61P25/14, A61P25/16